Jan Šperl

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Stefan Zeuzem, Peter Ferenci, Jan Šperl et al. · Journal of Hepatology · 2005 · 463 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Rajeshwar P. Mookerjee, Marco Pavesi, Karen Louise Thomsen et al. · Journal of Hepatology · 2015 · 241 citations · Full text

Veterinary Medicine, Pharmacotherapy, Inflammation +11

Strategies to manage hepatitis<scp>C</scp>virus (<scp>HCV</scp>) disease burden

Heiner Wedemeyer, A.‐S. Duberg, Marı́a Buti et al. · Journal of Viral Hepatitis · 2014 · 181 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +13

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 150 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutical Policy +13